We use cookies to improve your experience on our Website. We need cookies to continuously improve the services, to enable certain features and when embedding services or content of third parties, such as video player. By using our website, you agree to the use of cookies. We use different types of cookies. You can personalize your cookie settings here:

Show detail settings
Please find more information in our privacy statement.

There you may also change your settings later.

News

DZD Researchers Honored at the 2019 Diabetes Congress

The German Diabetes Society (DDG) honors several researchers of the German Center for Diabetes Research (DZD) at its congress in Berlin (May 28th to June 1st). Prof. Dr. med. Dr. h.c. Matthias Tschöp will receive the Paul Langerhans Medal, the highest award of the DDG.

 

The German Diabetes Society has been awarding the medal, named after the German pathologist Paul Langerhans, to top international diabetology researchers for more than 40 years. This year, the diabetes researcher Tschöp is honoured with the award. Tschöp has been CEO and Scientific Director of Helmholtz Zentrum München, a partner of the DZD, since August 2018.
Over the last 25 years, the physician has deciphered crucial signaling pathways of communication between the intestine and the brain. Based on these discoveries, he succeeded in combining the effects of several natural hormones in one molecule: Together with the chemist Richard DiMarchi, Tschöp developed a series of new drug candidates for the treatment of obesity and type 2 diabetes, including dual agonists with activity at the GLP-1/Glucagon and GLP-1/GIP receptors and a triple agonist with activity at all three GLP-1/GIP and glucagon receptors. Some of these polyagonists have been successfully tested in diabetes and obesity patients and are now in Phase 2 and 3 clinical trials. A dual GIP/GLP-1 receptor agonist, for example, lowered blood sugar and obesity more successfully than conventional GLP-1 monoagonists.  

From left: Prof. Matthias Tschöp und Prof. Martin Heni. Source: DZD

The Ferdinand Bertram Prize, endowed with 20,000 euros, goes to the DZD scientist Prof. Dr. Martin Heni. The physician works at the University Hospital in Tübingen and at the Institute for Diabetes Research and Metabolic Diseases at Helmholtz Zentrum München at the University of Tübingen (IDM). He is investigating how the human brain controls metabolism in the entire body and how disorders lead to obesity and diabetes.

In addition, further DDG research prizes and awards will be awarded to DZD scientists.

  • DZD Executive Board Member Prof. Dr. Hans-Ulrich Häring of the Institute for Diabetes Research and Metabolic Diseases of Helmholtz Zentrum München at the University of Tübingen (IDM) will be awarded the DDG badge of honor in gold.
  • The Werner Creutzfeldt Prize will be awarded to Prof. Dr. Andreas Pfeiffer from the German Institute of Human Nutrition (DIfE).
  • Dr. Isabel Serr of Helmholtz Zentrum München will be honored with the Silvia King Prize.
  • The Helmut Otto Medal will go to Prof. Dr. Norbert Hermanns and Prof. Dr. Bernhard Kulzer, Bad Mergentheim.

In addition, the DDG funds projects that are particularly worthy of support. Here too, research projects from the DZD were successful:

The Hellmut Mehnert Project Grant will go to Dr. Heike Vogel (DIfE). Prof. Dr. Christian Herder of the German Diabetes Center (DDZ) will receive the Menarini Project Grant. In addition, the research of Prof. Dr. Antje Körner of the Integrated Research and Treatment Center (IFB) Adiposity Diseases in Leipzig will be awarded the Hans Christian Hagedorn Project Grant.